
Brightmind.AI is developing AI-powered, personalized neurotechnology solutions for brain health challenges, starting with migraine prevention. Their non-invasive brain stimulation headset uses transcranial magnetic stimulation (TMS) and advanced brain monitoring to optimize neural activity. The company aims to make these solutions accessible worldwide for conditions like pain relief, cognitive decline, and depression. Their approach focuses on a novel, effective, and convenient at-home treatment. They have completed prototype development and clinical trials, with a market launch planned for 2026.

Brightmind.AI is developing AI-powered, personalized neurotechnology solutions for brain health challenges, starting with migraine prevention. Their non-invasive brain stimulation headset uses transcranial magnetic stimulation (TMS) and advanced brain monitoring to optimize neural activity. The company aims to make these solutions accessible worldwide for conditions like pain relief, cognitive decline, and depression. Their approach focuses on a novel, effective, and convenient at-home treatment. They have completed prototype development and clinical trials, with a market launch planned for 2026.